Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 August 2023 | Story Lunga Luthuli | Photo Francois van Vuuren
Bloemfontein Campus Solar Farm
The solar plant on the UFS’s Bloemfontein Campus, part of the university’s commitment to combatting loadshedding and embracing sustainable energy.

The University of the Free State (UFS) has installed solar plants across its three campuses.

The university says this is in response to the call for urgent solutions to loadshedding and the promotion of environmentally sustainable, cleaner, and renewable energy solutions.

Nicolaas Esterhuysen, Director of Engineering Services at UFS University Estates, said,

“The PV (photovoltaic) systems are grid-tied without storage to ensure maximum benefits and faster payback periods.”

Esterhuysen said the UFS has saved up to R32,5 million since the first solar plant was commissioned in 2017 to help the UFS reduce the impact of loadshedding and its carbon footprint and energy costs. “This will substantially increase this year with the commissioning of two large new ground-mounted solar plants on the Bloemfontein Campus,” he said.

“The microgrid installation on Qwaqwa Campus is one of the biggest solar diesel hybrid systems installed in South Africa. It allows us to keep the campus running despite excessive power interruptions.”

The UFS is currently embarking on research as part of the Grid-related Research Group (GRRP) under the Interdisciplinary Centre for Digital Futures (ICDF) to also help staff and students with understanding renewable energy and sustainability.

Esterhuysen said the plants are further evidence of the UFS’s commitment to renewable and energy saving solutions. “It is our flagship project, but our focus is also on energy saving initiatives – to ensure we are becoming more energy efficient and eliminate energy wastage. We have plans for expansion on all campuses. Some of the highlights are an off-grid solution for the new student centre at Qwaqwa Campus and to make South Campus a self-sustaining campus.”

The installed grid-tied system solar plants are operating without batteries on all three campuses, giving the university an optimal configuration between capital cost and payback period.


The energy generated at the solar plants:

Bloemfontein Campus – 3688 kWp

Qwaqwa Campus – 918 kWp

South Campus – 759 kWp

Paradys – 125 kWp

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept